Pharmafile Logo
Pharmafocus logo
Advanced Search

Aslan

Showing 2 posts of 2 posts found.

Aslan Pharmaceuticals appoints eminent cancer researcher to chair scientific advisory board

January 28, 2016
Research and Development Aslan, Professor Sir David Lane

Aslan Pharmaceuticals has appointed four global cancer experts to its new scientific advisory board.The Board will be chaired by the …

Appointment

Aslan licences promising cancer drug from Bristol-Myers Squibb

November 7, 2011
Research and Development, Sales and Marketing Aslan, BMS, Cancer

Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025